Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2 🔗 Access full article via ASM Journal of VirologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
